Breast Cancer

Watch our video to learn more about the Xilis MOS platform and how it selects the optimal therapy choice for each individual patient.

Publications and Abstract Index Utilizing MOS Technology

Title: Micro-organospheres: an automated patient-derived model platform for rapid drug screening of breast cancer.

We have now shown the feasibility of establishing micro-organospheres as a rapid, scalable, and cost-effective platform to study patient-derived BC drug response.